Please assess the completion status of the following clinical trial:

Trial Title: ChloraPrep Versus Betadine for Elective Knee Replacement Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled to undergo primary total knee arthroplasty~* Age 18 or over~Exclusion Criteria:~* Inability to provide informed consent or to comply with study assessments due to cognitive impairment or geographic distance~* Age 17 or younger~* Allergies to chlorhexadine gluconate or povidone iodine~* Topical antimicrobial use within 14 days of surgery~* Any active dermatoses or open wounds over the operative site~* Any condition requiring antibiotics 14 days prior to arriving for surgery~* Patients with chronic immunosuppression (such as HIV/AIDS)~* Unable to adhere to follow up schedule and treatment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: ACTIVE_COMPARATOR): Subjects randomized to Arm 1 will receive Betadine surgical scrub at the time of primary total knee arthroplasty.
- Arm 2 (Type: ACTIVE_COMPARATOR): Subjects in Arm 2 will receive ChloraPrep surgical scrub prior to elective primary total knee arthroplasty.

Based on this trial design, predict the completion outcome and termination type (if applicable).